DOI: https://doi.org/10.22263/2312-4156.2025.2.92
A.N. Mikhailov1, H.V. Damantsevich2
Radiation imaging of multiple myeloma
1The Institute for Advanced Training & Retraining of Healthcare Personnel of the educational institution “Belarusian State Medical University”, Minsk, Republic of Belarus
2State Institution “Republican Scientific and Practical Center for Radiation Medicine and Human Ecology”, Gomel, Republic of Belarus
Vestnik VGMU. 2025;24(2):92-105.
Abstract.
The article highlights current issues of using low-dose X-ray computed tomography (LDXCT) in radiation visualization of a very dangerous disease – multiple myeloma in Rustitsky-Kahler disease. The resolving power of LDXCT is quite high. Osteolytic foci are detected even at the size of 5 mm. The correlation between the number of detected osteolytic foci and the stage of the disease has been proven. The method of low-dose X-ray computed tomography has high diagnostic efficiency compared to the alternative method of conventional radiography, which was the «gold standard» of visualization of this disease in detecting extraosseous changes, pathological fractures and other pathological formations. The results of the studies in 109 patients with newly diagnosed multiple myeloma indicate the prospects of LDXCT for a wider application in clinical practice and the possibility of revising the existing diagnostic standards.
Keywords: multiple myeloma, radiation imaging, radiography, X-ray low-dose computed tomography.
References
1. Marchenko YaM. Multiple myeloma. Vestnik Molodogo Uchenogo. 2016;14(3):25-30. (In Russ.)
2. Rajkumar SV. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. American Journal Hematology. 2016 Jul;91(7):719-734. doi: http://dx.doi.org/10.1002/ajh.24402
3. Landgren O, Kyle RA, Pfeiffer RM, J. A. Katzmann, N. E. Caporaso, R. B. Hayes, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009 May;113(22):5412-5417. doi: http://dx.doi.org/10.1182/blood-2008-12-194241
4. Kravchenko DV, Khoduleva SA, Novik DK. Multiple myeloma: prakt posobie dlya vrachei. Gomel, RB: RNPTs RM i ECh; 2016. 83 р. (In Russ.)
5. Cheshik AA. Analysis of the incidence of multiple myeloma in the Republic of Belarus. Chelovek Ego Zdorov'e. 2016;(4):54-59. (In Russ.)
6. Mikhaylov AN. X-ray diagnosis of diseases of the bone and joint system. Minsk, RB: BelMAPO; 2011. 299 р. (In Russ.)
7. Rajkumar SV, Dimopoulos MA, Palumbo A. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncology. 2014 Nov;15(12):e538-е548. doi: http://dx.doi.org/10.1016/S1470-2045(14)70442-5
8. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer. 1975 Sep;36(3):842-854. doi: http://dx.doi.org/10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u
9. On approval of clinical protocols for diagnosis and treatment of patients: pri-kaz M-va zdravookhraneniya Resp Belarus' ot 19 maya 2005 g № 274: v red ot 21 iyulya 2016 g № 685. V: Etalon: inform-poiskovaya sistema [Accessed 19th March 2025].
10. Bessmeltsev SS. Multiple myeloma (pathogenesis, clinic, diagnosis, differential diagnosis). Part I. Klinicheskaya Onkogematologiya Fundamental'nye Issle-dovaniya Klinicheskaya Praktika. 2013;6(3):237-257. (In Russ.)
11. Kostina IE, Gitis MK, Mendeleeva LP, Bagramyan AYu, Solovyev MV, Gribanova EO, i dr. X-ray computed tomography in the diagnosis and monitoring of bone lesions in multiple myeloma using low-dose and standard scanning protocols. Gematologiya Transfuziologiya. 2018;63(2):113-123. (In Russ.)
12. Zamagni E, Tacchetti P, Cavo M. Imaging in multiple myeloma: How? When? Blood. 2019 Feb;133(7):644-651. doi: http://dx.doi.org/10.1182/blood-2018-08-825356
13. Bessmeltsev SS, Abdulkadyrov KM. Multiple myeloma: ruk dlya vrachei. Saint Petersburg, RF: Dialekt; 2004. 446 р. (In Russ.)
14. Zaidi O, Danisa OA, Cheng W. Measurement Techniques and Utility of Hounsfield Unit Values for Assessment of Bone Quality Prior to Spinal Instrumentation: A Review of Current Literature. Spine (Phila Pa 1976). 2019 Feb;44(4):E239-E244. doi: http://dx.doi.org/10.1097/BRS.0000000000002813
15. Horger M, Pereira P, Claussen CD. Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters. British Journal Radiology. 2008 May;81(965):386-96. doi: http://dx.doi.org/10.1259/bjr/21850180
16. Mamaeva EA, Solovyeva MV, Mendeleeva LP. Multiple myeloma complicated by bone plasmacytomas: pathogenesis, clinical presentation, treatment approaches (literature review). Klinicheskaya Onkogematologiya Fundamental'nye Issledovaniya Klinicheskaya Praktika. 2023;16(3):303-310. (In Russ.)
17. Firsova MV, Mendeleeva LP, Kovrigina AM, M. V. Solovev, V. G. Savchenko. Plasmacytoma in patients with multiple myeloma: Morphology and immunohistochemistry. BMC Cancer. 2020 Apr;20(1):346. doi: http://dx.doi.org/10.1186/s12885-020-06870-w
Submitted 03.02.2025
Accepted 14.04.2025
Information about authors:
A.N. Mikhailov – Doctor of Medical Sciences, Professor, Academician of Medicine of the National Academy of Sciences of Belarus, head of Chair of Radiation Diagnostics, Institute for Advanced Training & Retraining of Healthcare Personnel of the Educational Institution “Belarusian State Medical University”;
Hanna V. Damantsevich – postgraduate student of the Chair of Radiation Diagnostics, Institute for Advanced Training & Retraining of Healthcare Personnel of the Educational Institution “Belarusian State Medical University”; radiologist, Republican Scientific and Practical Center for Radiation Medicine and Human Ecology, e-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра..
